H1B Salary Data

Home › Employers › Icahn School of Medicine at Mount Sinai › Bioinformatician I

Bioinformatician I at Icahn School of Medicine at Mount Sinai: H-1B salaries

16 labor condition applications for the job title Bioinformatician I at Icahn School of Medicine at Mount Sinai. Median offered base salary $79,500; middle half $73,694–$82,337.

Applications (LCAs)16
Median offered salary$79,500
Middle half of salaries$73,694–$82,337
10th–90th percentile$72,000–$82,867

By fiscal year

Fiscal yearLCAsMedian salary
FY20234$75,347
FY20244$72,000
FY20255$80,000
FY20263$82,867

Applications

Base salaryLocationSubmittedStart dateStatus
$82,867
Level II		New York, NYDec 30, 2025Feb 2, 2026Certified
$82,867
Level II		New York, NYDec 23, 2025Feb 1, 2026Certified
$82,867
Level II		New York, NYNov 10, 2025Feb 27, 2026Certified
$80,000
Level I		New York, NYJun 27, 2025Aug 1, 2025Certified
$80,000
Level I		New York, NYJun 27, 2025Aug 1, 2025Certified
$82,160
Level I		New York, NYApr 4, 2025May 30, 2025Certified
$87,610
Level II		New York, NYMar 24, 2025Apr 15, 2025Certified
$77,126
E-3 · Level I		New York, NYFeb 12, 2025Mar 17, 2025Certified
$72,000
Level II		New York, NYJun 28, 2024Sep 1, 2024Certified
$71,677
Level II		New York, NYJun 14, 2024Aug 5, 2024Certified
$72,000
Level II		New York, NYMay 15, 2024Jun 24, 2024Certified
$78,999
Level II		New York, NYMar 22, 2024Jun 14, 2024Certified
$82,000
Level I		New York, NYJun 5, 2023Sep 25, 2023Certified
$73,694
Level I		New York, NYMar 8, 2023Jun 5, 2023Certified
$73,694
Level I		New York, NYFeb 9, 2023Mar 31, 2023Certified
$77,000
Level I		Ann Arbor, MIDec 8, 2022Feb 26, 2023Certified

Bioinformatician I at all employers →

Other jobs at Icahn School of Medicine at Mount Sinai

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).